1. Market Research
  2. > Pharmaceutical

Pharmaceutical Market Research: Pharma Industry Analysis Reports

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
103 votes

Global Pharmaceutical Industry Overview

The pharmaceutical industry consists of companies involved in the research, development and marketing of drugs and biologics.

The pharmaceutical market was valued at $1 trillion in 2013, according to IMS. The market grew at a 4% compound annual growth rate (CAGR) from 2009 to 2013. It grew well in 2010 and 2011 before a decline in growth in 2012 and 2013.

Pharmaceutical Market Value in USD from 2009 to 2013

The pharmaceutical market was driven by a rise in healthcare spending and high growth in both emerging markets and the biologics segment. In 2013, cancer was the largest segment, accounting for 7% ($67 billion) of the global industry. This was closely followed by the pain and diabetes segments with shares of 6% and 5% respectively, according to IMS.

Key Pharmaceutical International Markets

  • North America was the largest market in 2013, with revenues exceeding $340 billion.
  • This was followed by Europe with revenues of $224 billion according to IMS.
  • Emerging countries in Asia and Latin America are forecast to grow rapidly. Increase in spending in these countries will be driven by rising incidence of disease, favorable government policies and improving healthcare infrastructure (and the multiplication of drug stores and pharmacies in large cities.

 Top Pharmaceutical Regional Markets' Growth in 2013

Pharmaceutical Industry Key Players

Novartis was the pharmaceutical market leader in 2013 (thanks to a state-of-the-art drug discovery and development department) with revenues of $51 billion and a market share of 5%. Primary contributors to its sales were the drugs Gilenya and Affinitor. In 2014 Novartis is expected to file 10 new drugs with the U.S.’s Federal Drugs Administration (FDA). Pfizer was close behind Novartis with a 4% share of the global market according to IMS. Pfizer too is expected to file six new drugs with the FDA in 2014.

The top ten players are forecast to collectively lose share from 35% in 2013 to 30% in 2017, according to IMS. Patent expiries over the next few years will eat into the revenues of most companies during this period.

Sanofi potential loss due to patent expiries is estimated to reach up to $8.1 billion. The company is then followed by Novartis, Roche, Astra-Zeneca and Eli Lilly with respectively potential losses of 7.7, 7.2, 6.7 and 6 billion dollars.  

Pharmaceutical Market Sales Forecast 

Pharmaceutical industry trends show that the global market is set to show steady growth in the next five years at a CAGR of 4-5%. Innovative on-prescritpion drugs and over-the-counter drugs entering the market and biologics such as targeted therapies for cancer will be key in driving growth.

Key Trends and Strategies for Growth in the Pharmaceutical Market

Four trends are shaping pharmaceutical markets.

New Government Policies are Expanding Healthcare Coverage

Expanded patient coverage is a key trend in the pharmaceutical market. China has increased its healthcare spending to $116 billion as part of its latest 12 year plan. India has created a $5 billion policy aimed at providing health services to government hospitals and clinics, especially in the rural areas. The U.S. Affordable Care Act and the U.K. Health and Social Care Act also create opportunities.

The differing nature of the policies means pharmaceutical companies must adapt their marketing strategies for each region or country. A ‘one size fits all’ strategy will no longer work.

Emerging Pharmaceutical Markets are Improving Healthcare Provision

Improving healthcare provision, increased incidence of chronic diseases, the appearance of safer drug delivery systems and medical tourism are driving pharmaceutical industries in emerging markets. Branded drugs penetration is about 25% (due to the importance of generic drugs) as compared to about 75% in developed economies, according to IMS, giving the potential for expansion in the branded sector. 

Pharmaceuticals companies should focus on these emerging markets. 

Read more ┬╗

Share
24/7 Customer Support

Talk to Sam

+1 718 473 0872

1-10 of about 46000 reports

Global Pharmaceutical Industry

  • June 2016
    8 pages
  • Pharmaceutical  

  • World  

    Europe  

    Japan  

View report >

Pharmaceutical Industry in the US - Forecast

  • October 2016
    8 pages
  • Pharmaceutical  

  • United States  

View report >

Pharmaceutical Industry in the UK and Europe - Forecast

  • October 2016
    21 pages
  • Pharmaceutical  

  • United Kingdom  

    Europe  

    United States  

View report >

The future of the Pharmaceutical Industry in Japan and Asia

  • January 2015
    9 pages
  • Occupational He...  

    Pharmaceutical  

  • Japan  

    Asia  

View report >

Pharmaceutical Industry in Japan

  • October 2016
    8 pages
  • Pharmaceutical  

  • Japan  

View report >

Pharmaceutical Industry in France

  • May 2016
    61 pages
  • France  

    United States  

View report >

Pharmaceutical Industry in Germany

  • March 2016
    11 pages
  • Germany  

    China  

    Europe  

View report >

Pharmaceutical Industry in Italy

  • October 2016
    10 pages
  • Pharmaceutical  

  • Italy  

    Europe  

    Germany  

View report >

Pharmaceutical Industry in the UK

  • November 2016
    35 pages
  • Pharmaceutical  

  • United Kingdom  

    Europe  

View report >


About 25000 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 75 - $ 47500)

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers In 32 Countries: Supplier Shares And ...

October 2016 $ 47400

2016 Cancer Diagnostic Testing Analyzers And Reagents I ...

October 2016 $ 47400

2016 Europe Tumor Marker Testing In 28 Countries: Suppl ...

October 2016 $ 34500

2016 Europe Immunodiagnostic Analyzers And Reagents In ...

October 2016 $ 34500

2016 Europe Cancer Diagnostic Testing Analyzers And Rea ...

October 2016 $ 34500

Immunodiagnostics 2020: Supplier Shares And Strategies, ...

October 2016 $ 23500

2016 Clinical Chemistry And Immunodiagnostic Analyzers ...

September 2016 $ 23500

Immunodiagnostics Market 2017-2021: Us, Europe, Japan-- ...

December 2016 $ 23500

Europe Tumor Markers: Supplier Shares By Test, Competit ...

October 2016 $ 12800

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.